FILE:A/A-8K-20110118165016.txt.gz
EVENTS:	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
TEXT:
ITEM: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
           
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
           
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
           
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
           
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
Item 5.02.
                                       
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
 
(d)  On January 12, 2011, the Board of Directors of Agilent Technologies, Inc. (the "Company"), upon the recommendation of its Nominating/Corporate Governance Committee, increased the size of the Board of Directors from 8 to 9 members and elected Dr. Tadataka Yamada to the vacancy created.  Dr. Yamada was elected to serve in the class of directors that will stand for re-election at the 2013 Annual Meeting of Stockholders.  Dr. Yamada will serve on the Compensation Committee and Nominating/Corporate Governance Committee of the Company's Board of Directors.
 
There are no arrangements or understandings between Dr. Yamada and any other person pursuant to which he was appointed as a director and no transactions to which the Company is a party and in which Dr. Yamada has a material interest that are required to be disclosed under Item 404(a) of Regulation S-K.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 


